These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35694931)

  • 1. INCEPTUS Natural History, Run-in Study for Gene Replacement Clinical Trial in X-Linked Myotubular Myopathy.
    Dowling JJ; Müller-Felber W; Smith BK; Bönnemann CG; Kuntz NL; Muntoni F; Servais L; Alfano LN; Beggs AH; Bilder DA; Blaschek A; Duong T; Graham RJ; Jain M; Lawlor MW; Lee J; Coats J; Lilien C; Lowes LP; MacBean V; Neuhaus S; Noursalehi M; Pitts T; Finlay C; Christensen S; Rafferty G; Seferian AM; Tsuchiya E; James ES; Miller W; Sepulveda B; Vila MC; Prasad S; Rico S; Shieh PB;
    J Neuromuscul Dis; 2022; 9(4):503-516. PubMed ID: 35694931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial.
    Shieh PB; Kuntz NL; Dowling JJ; Müller-Felber W; Bönnemann CG; Seferian AM; Servais L; Smith BK; Muntoni F; Blaschek A; Foley AR; Saade DN; Neuhaus S; Alfano LN; Beggs AH; Buj-Bello A; Childers MK; Duong T; Graham RJ; Jain M; Coats J; MacBean V; James ES; Lee J; Mavilio F; Miller W; Varfaj F; Murtagh M; Han C; Noursalehi M; Lawlor MW; Prasad S; Rico S
    Lancet Neurol; 2023 Dec; 22(12):1125-1139. PubMed ID: 37977713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world analysis of healthcare resource utilization by patients with X-linked myotubular myopathy (XLMTM) in the United States.
    Graham RJ; Darras BT; Haselkorn T; Fisher D; Genetti CA; Miller W; Beggs AH
    Orphanet J Rare Dis; 2023 Jun; 18(1):138. PubMed ID: 37280644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) in X-Linked Myotubular Myopathy: Content Validity and Psychometric Performance.
    Duong T; Harding G; Mannix S; Abel C; Phillips D; Alfano LN; Bönnemann CG; Lilien C; Lowes LP; Servais L; Warken-Madelung B; Nieto Bergman S; James ES; Noursalehi M; Prasad S; Rico S; Bilder DA
    J Neuromuscul Dis; 2021; 8(1):63-77. PubMed ID: 32925083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ASPIRO open-label clinical trial.
    Lawlor MW; Schoser B; Margeta M; Sewry CA; Jones KA; Shieh PB; Kuntz NL; Smith BK; Dowling JJ; Müller-Felber W; Bönnemann CG; Seferian AM; Blaschek A; Neuhaus S; Foley AR; Saade DN; Tsuchiya E; Qasim UR; Beatka M; Prom MJ; Ott E; Danielson S; Krakau P; Kumar SN; Meng H; Vanden Avond M; Wells C; Gordish-Dressman H; Beggs AH; Christensen S; Conner E; James ES; Lee J; Sadhu C; Miller W; Sepulveda B; Varfaj F; Prasad S; Rico S
    EBioMedicine; 2024 Jan; 99():104894. PubMed ID: 38086156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and health resource use in patients with X-linked myotubular myopathy: insights from US commercial claims.
    Sacks NC; Healey BE; Cyr PL; Slocomb T; James E; Beggs AH; Graham RJ
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1019-1026. PubMed ID: 33843254
    [No Abstract]   [Full Text] [Related]  

  • 7. Mortality and respiratory support in X-linked myotubular myopathy: a RECENSUS retrospective analysis.
    Graham RJ; Muntoni F; Hughes I; Yum SW; Kuntz NL; Yang ML; Byrne BJ; Prasad S; Alvarez R; Genetti CA; Haselkorn T; James ES; LaRusso LB; Noursalehi M; Rico S; Beggs AH
    Arch Dis Child; 2020 Apr; 105(4):332-338. PubMed ID: 31484632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing X-linked Myotubular Myopathy - A German 20-year Follow Up Experience.
    Gangfuss A; Schmitt D; Roos A; Braun F; Annoussamy M; Servais L; Schara-Schmidt U
    J Neuromuscul Dis; 2021; 8(1):79-90. PubMed ID: 33164942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput transcriptome analyses from ASPIRO, a phase 1/2/3 study of gene replacement therapy for X-linked myotubular myopathy.
    Andreoletti G; Romano O; Chou HJ; Sefid-Dashti MJ; Grilli A; Chen C; Lakshman N; Purushothaman P; Varfaj F; Mavilio F; Bicciato S; Urbinati F
    Am J Hum Genet; 2023 Oct; 110(10):1648-1660. PubMed ID: 37673065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-linked myotubular myopathy: A prospective international natural history study.
    Annoussamy M; Lilien C; Gidaro T; Gargaun E; Chê V; Schara U; Gangfuß A; D'Amico A; Dowling JJ; Darras BT; Daron A; Hernandez A; de Lattre C; Arnal JM; Mayer M; Cuisset JM; Vuillerot C; Fontaine S; Bellance R; Biancalana V; Buj-Bello A; Hogrel JY; Landy H; Servais L
    Neurology; 2019 Apr; 92(16):e1852-e1867. PubMed ID: 30902907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic Cholestasis Is a Clinically Significant Feature Associated with Natural History of X-Linked Myotubular Myopathy (XLMTM): A Case Series and Biopsy Report.
    Molera C; Sarishvili T; Nascimento A; Rtskhiladze I; Muñoz Bartolo G; Fernández Cebrián S; Valverde Fernández J; Muñoz Cabello B; Graham RJ; Miller W; Sepulveda B; Kamath BM; Meng H; Lawlor MW
    J Neuromuscul Dis; 2022; 9(1):73-82. PubMed ID: 34366366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory motor function in individuals with centronuclear myopathies.
    Smith BK; Renno MS; Green MM; Sexton TM; Lawson LA; Martin AD; Corti M; Byrne BJ
    Muscle Nerve; 2016 Feb; 53(2):214-21. PubMed ID: 26351754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A healthcare claims analysis to identify and characterize patients with suspected X-Linked Myotubular Myopathy (XLMTM) in the Brazilian Healthcare System.
    Souza PVS; Haselkorn T; Baima J; Oliveira RW; Hernández F; Birck MG; França MC
    Orphanet J Rare Dis; 2024 May; 19(1):188. PubMed ID: 38715109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of the Quality-of-Life Impact of X-Linked Myotubular Myopathy.
    Lloyd A; Aggio D; Slocomb TL; Lee J; Beggs AH; Bilder DA
    J Neuromuscul Dis; 2021; 8(6):1047-1061. PubMed ID: 34250946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A natural history study of X-linked myotubular myopathy.
    Amburgey K; Tsuchiya E; de Chastonay S; Glueck M; Alverez R; Nguyen CT; Rutkowski A; Hornyak J; Beggs AH; Dowling JJ
    Neurology; 2017 Sep; 89(13):1355-1364. PubMed ID: 28842446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs.
    Mack DL; Poulard K; Goddard MA; Latournerie V; Snyder JM; Grange RW; Elverman MR; Denard J; Veron P; Buscara L; Le Bec C; Hogrel JY; Brezovec AG; Meng H; Yang L; Liu F; O'Callaghan M; Gopal N; Kelly VE; Smith BK; Strande JL; Mavilio F; Beggs AH; Mingozzi F; Lawlor MW; Buj-Bello A; Childers MK
    Mol Ther; 2017 Apr; 25(4):839-854. PubMed ID: 28237839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, retrospective medical record review of X-linked myotubular myopathy: The recensus study.
    Beggs AH; Byrne BJ; De Chastonay S; Haselkorn T; Hughes I; James ES; Kuntz NL; Simon J; Swanson LC; Yang ML; Yu ZF; Yum SW; Prasad S
    Muscle Nerve; 2018 Apr; 57(4):550-560. PubMed ID: 29149770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatobiliary disease in XLMTM: a common comorbidity with potential impact on treatment strategies.
    D'Amico A; Longo A; Fattori F; Tosi M; Bosco L; Chiarini Testa MB; Paglietti MG; Cherchi C; Carlesi A; Mizzoni I; Bertini E
    Orphanet J Rare Dis; 2021 Oct; 16(1):425. PubMed ID: 34641930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy.
    Ross JA; Tasfaout H; Levy Y; Morgan J; Cowling BS; Laporte J; Zanoteli E; Romero NB; Lowe DA; Jungbluth H; Lawlor MW; Mack DL; Ochala J
    Acta Neuropathol Commun; 2020 Oct; 8(1):167. PubMed ID: 33076971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of systemic gene therapy in a canine model of myotubular myopathy.
    Elverman M; Goddard MA; Mack D; Snyder JM; Lawlor MW; Meng H; Beggs AH; Buj-Bello A; Poulard K; Marsh AP; Grange RW; Kelly VE; Childers MK
    Muscle Nerve; 2017 Nov; 56(5):943-953. PubMed ID: 28370029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.